revolution
investors keen to invest in early-stage businesses
which have the potential to create disproportionate
value. IAN in addition to money provides constant
access to high quality mentoring, vast networks and
inputs on strategy as well as execution.
implements its mandate through a wide range
of impact initiatives, be it providing access to risk
capital through targeted funding, technology
transfer, IP management and hand holding
schemes that help bring innovation excellence
to the biotech firms.
